- Coordinator
- Universiteit Gent, Belgium
- Runs
- 1 June 2022 to 30 September 2026
- Status
- Running
- EU funding
- €8.0m
- Total cost
- €8.1m
- Partners
- 12 organisations in 9 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101057816
What the project is doing
In the project's own words, from its summary on CORDIS.
TransPharm two-track approach focusses on the one hand on the compounds itself by identifying greener and more sustainable-by-design Active Pharmaceutical Ingredients (APIs) and on the other hand reducing the environmental impact and resilience of the manufacturing process by optimizing the synthesis route of new APIs in continuous flow and by proposing greener alternative solvents. The aim of the project is to (i) analyse and predict flow behaviour and environmental biodegradability of APIs and their synthesis pathways; (ii) identify greener and more sustainable alternatives to pharmaceutical products / APIs of concern; (iii) reduce the footprint and create important shortcuts in synthetic schemes of APIs; and (iv) assess the sustainability of pharmaceuticals over their entire life cycle.
To reach the envisaged aims, the project will deliver four toolboxes (consisting of digital tools and guidelines) for the development of greener pharmaceutical products and APIs. These toolboxes will be used to (v) assess the potential to move towards the transition to greener, more agile pharmaceutical production. In addition, TransPharm will elaborate on the business case for sustainable pharmaceutical products or APIs and what is needed to bring them to the market.
The project will also make sure that (vi) key project results and knowledge are properly transferred towards targeted stakeholders. TransPharm?s outcome contribute to a Europe, that is self-sufficient by reducing dependence on API production in third countries; making the EU healthcare industry more competitive, sustainable and reliable, ensuring timely supply of essential medicines from particularly complex or critical supply and distribution chains and positioning EU as a leader in innovative technologies.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universiteit Gent | Gent | Belgium | Coordinator |
| Ecologic Institut Gemeinnutzige GmbH | Berlin | Germany | Participant |
| Leuphana Universitat Luneburg | Luneburg | Germany | Participant |
| Helsingin Yliopisto | Helsinki | Finland | Participant |
| Orion Oyj | Espoo | Finland | Participant |
| Benkei | Lyon | France | Participant |
| Kelada Pharmachem Limited | Dublin | Ireland | Participant |
| Valsts zinatniskais instituts ""Nacionalais petniecibas un inovaciju instituts"""" | Riga | Latvia | Participant |
| Rijksinstituut Voor Volksgezondheid En Milieu (rivm) | Bilthoven | Netherlands | Participant |
| Stichting Radboud Universiteit | Nijmegen | Netherlands | Participant |
| Circa Group AS | Oslo | Norway | Participant |
| University of York | York North Yorkshire | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI